65 related articles for article (PubMed ID: 698934)
41. Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
Ellims PH
Cancer Chemother Pharmacol; 1982 Dec; 10(1):1-6. PubMed ID: 6186411
[TBL] [Abstract][Full Text] [Related]
42. Some aspects of size-dependent differential drug response in primary and metastatic tumors.
Abe I; Suzuki M; Hori K; Saito S; Sato H
Cancer Metastasis Rev; 1985; 4(1):27-39. PubMed ID: 3888381
[TBL] [Abstract][Full Text] [Related]
43. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
Bhalla K; Grant S
Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
[TBL] [Abstract][Full Text] [Related]
44. Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.
Cohen JD; Robins HI; Javid MJ
J Neurooncol; 1990 Aug; 9(1):1-8. PubMed ID: 2213112
[TBL] [Abstract][Full Text] [Related]
45. Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells.
Tsuboi KK; Edmunds NH; Kwong LK
Cancer Res; 1977 Sep; 37(9):3080-7. PubMed ID: 884665
[TBL] [Abstract][Full Text] [Related]
46. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
47. [Biochemical modulation of 5-FU by thymidine and N-phosphoacetyl-L-aspartate: the relation between 5-FU incorporation into RNA and its cytocidal effect].
Akazawa S; Kumai R; Shimizu K; Ayusawa D; Seno T; Yoshida S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):990-5. PubMed ID: 3963863
[TBL] [Abstract][Full Text] [Related]
48. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
Ardalan B; Glazer RI; Kensler TW; Jayaram HN; Van Pham T; Macdonald JS; Cooney DA
Biochem Pharmacol; 1981 Aug; 30(15):2045-9. PubMed ID: 7295324
[No Abstract] [Full Text] [Related]
49. Antiproliferative agents and differential survival between normal and cancer cells.
Tsuboi KK; Kwong LK
Cancer Res; 1978 Nov; 38(11 Pt 1):3745-50. PubMed ID: 698934
[TBL] [Abstract][Full Text] [Related]
50. m-AMSA and PALA: two new agents in cancer chemotherapy.
Rozencweig M; Von Hoff DD; Cysyk RL; Muggia FM
Cancer Chemother Pharmacol; 1979; 3(3):135-41. PubMed ID: 393427
[TBL] [Abstract][Full Text] [Related]
51. Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review.
Grem JL; King SA; O'Dwyer PJ; Leyland-Jones B
Cancer Res; 1988 Aug; 48(16):4441-54. PubMed ID: 3293772
[No Abstract] [Full Text] [Related]
52. Role of thymidine in biochemical modulation: a review.
O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
